市場調查報告書

皮膚灌注壓力測試設備市場增長,趨勢,預測(2020-2025)

Skin Perfusion Pressure Testing Devices Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 946276
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
皮膚灌注壓力測試設備市場增長,趨勢,預測(2020-2025) Skin Perfusion Pressure Testing Devices Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 110 Pages
簡介

在2020年至2025年的預測期內,皮膚灌注壓力測試設備市場預計將以5.1%的複合年增長率增長。

市場增長的驅動力是周圍動脈疾病的患病率上升,糖尿病的患病率上升和技術進步。

外周動脈疾病(PAD)是由於斑塊積聚導致血管變窄或阻塞而引起的。如果不加以治療,則可能導致組織死亡,心臟病,動脈瘤或腎臟疾病。根據美國國立衛生研究院公佈的最新調查,年齡在50歲以上的美國人中有20人中有1人患有PAD。隨著人口的增長,該疾病的患病率也在增加,到2050年,全球患者人數將從960萬增加到1900萬。隨著世界人口的老齡化,PAD在未來將變得越來越普遍。因此,PAD患者的數量正在以更快的速度增長,並最終推動了皮膚灌注壓力測試設備的市場。例如糖尿病患病率的上升和技術進步,已經擴大了皮膚灌注壓力測試設備的使用。

該報告調查了皮膚灌注壓力測試設備市場,並分析了市場概況,市場增長因素和障礙因素的分析,市場規模趨勢以及按類型和地區,競爭狀況以及主要公司的概況進行的預測。 有關市場機會的綜合信息等。

內容

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場增長因素
    • 周圍動脈疾病的患病率增加
    • 糖尿病患病率上升
    • 技術進步
  • 市場約束因素
    • 缺乏熟練的人力資源
  • 波特的五力分析

第5章市場細分

  • 按產品類型
    • 超聲波皮膚灌注壓力測試儀
    • 激光多普勒皮膚灌注壓力測試儀
    • 光體積描記法皮膚灌注壓力測試裝置
  • 按模式
    • 基於購物車的設備
    • 便攜式設備
  • 按最終用戶
    • 醫院
    • 門診手術中心
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • ADInstruments
    • CorVascular Diagnostics, LLC
    • Koven Technology
    • Moor Instruments Limited
    • Perimed AB
    • Promed Group
    • Vasamed
    • Viasonix

第7章市場機會和未來趨勢

目錄
Product Code: 69914

The Skin Perfusion Pressure Testing Devices market studied is anticipated to grow with a CAGR of nearly 5.1%, during the forecast period.

Certain factors that are driving the market growth include rising prevalence of peripheral artery disease, increasing prevalence of diabetes, and technological advancements.

Peripheral arterial disease (PAD) is caused by a narrowing or blocking of the blood vessels due to a plaque build-up. This condition can lead to tissue death, heart stroke, aneurysms, or kidney diseases, if left untreated. According to the latest available report published by the National Institute of Health, one in every 20 Americans, who are over the age of 50, has PAD. It has been affecting 8 to 12 million people in the United States, especially those over 50 years. As the population is growing, the prevalence of the disease is also increasing, which could grow from 9.6 million to reach 19 million overall, globally by 2050. With the aging of the global population, it seems likely that PAD will be increasingly common in the future. Hence, the statistics show that the number of PAD is increasing at a faster pace, which is ultimately driving the market of Skin Perfusion Pressure Testing Devices. Other factors, such as the rising prevalence of diabetes and the technological advancements have broadened the range of the Skin Perfusion Pressure Testing Devices.

Key Market Trends

Ambulatory Surgical Centers show Lucrative Opportunity in the Global Skin Perfusion Pressure Testing Devices Market

  • Ambulatory center means a facility, located in or apart from a hospital, that provides, under the direction of a licensed physician, either diagnosis or treatment, or both, to ambulatory patients in need of medical, surgical, or mental care.
  • Throughout the past few decades, the treatment of peripheral artery diseases, diabetic foot ulcers, etc. has been increasingly prioritized by the global health community or governments even in low- and middle-income countries. As a result, the demand for skin perfusion pressure testing has risen significantly, in order to address the global disease burden, thus leading to a rise in the utilization and adoption of Skin Perfusion Pressure Testing Devices.
  • Over the past few years, with the move to value-based care, hospitals and healthcare systems are facing extreme competition from outpatient service sites, particularly those which offer physician office-based procedures, and ambulatory surgery. Gaining in popularity across the globe, Ambulatory Surgical Centers provide both operational and economic efficiencies, enabling ease of patient access, very competitive pricing, and increased opportunities for physician engagement. Hence, owing to all the aforementioned factors, the studied market is expected to increase in the future.

North America Dominates the Global Skin Perfusion Pressure Testing Devices Market

North American dominates the Skin Perfusion Pressure Testing Devices products market primarily due to the rising incidence of cardiovascular and other chronic diseases, growing geriatric population, and the strong presence of industry players in the region.

According to the International Journal of Epidemiology, 2019, around 610,000 people die due to one or the other heart diseases annually in the United States. Furthermore, approximately 735,000 people in the United States experience heart attack each year.

Asia-Pacific is anticipated to grow tremendously during the forecast period, owing to factors, such as a high prevalence of diabetes, a growing obese population, and government initiatives of raising awareness regarding healthcare. According to IDF, in 2019, USD 324.5 billion was spent on diabetes in the region, which is 42.7% of the total global health expenditure on diabetes.

Competitive Landscape

The global Skin Perfusion Pressure Testing Devices market is competitive and consists of a few major players. Companies like ADInstruments, CorVascular Diagnostics, LLC, Koven Technology, Moor Instruments Limited, Perimed AB, Promed Group, Vasamed, Viasonix, among others, hold the substantial market share in the market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Peripheral Artery Diseases
    • 4.2.2 Increasing Prevalence of Diabetes
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Personnels
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Ultrasound skin perfusion pressure testing devices
    • 5.1.2 Laser doppler skin perfusion pressure testing devices
    • 5.1.3 Photoplethysmography skin perfusion pressure testing devices
  • 5.2 By Mode
    • 5.2.1 Cart-based devices
    • 5.2.2 Portable devices
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory surgical centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ADInstruments
    • 6.1.2 CorVascular Diagnostics, LLC
    • 6.1.3 Koven Technology
    • 6.1.4 Moor Instruments Limited
    • 6.1.5 Perimed AB
    • 6.1.6 Promed Group
    • 6.1.7 Vasamed
    • 6.1.8 Viasonix

7 MARKET OPPORTUNITIES AND FUTURE TRENDS